Yüklüyor......

Do single‐arm trials have a role in drug development plans incorporating randomised trials?

Often, single‐arm trials are used in phase II to gather the first evidence of an oncological drug's efficacy, with drug activity determined through tumour response using the RECIST criterion. Provided the null hypothesis of ‘insufficient drug activity’ is rejected, the next step could be a rand...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pharm Stat
Asıl Yazarlar: Grayling, Michael J., Mander, Adrian P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4855632/
https://ncbi.nlm.nih.gov/pubmed/26609689
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1726
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!